DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Phendimetrazine tartrateis the generic ingredient in nineteen branded drugs marketed by Valeant, Numark, Graham Dm, Virtus Pharms, Shire Richwood, Mast Mm, Sandoz, Vitarine, Solvay, Teva, Ferndale Labs, Abc Holding, Camall, Chartwell Rx, Pvt Form, Forest Pharms, Barr, Elite Labs Inc, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mikart, Nexgen Pharma Inc, Nostrum Labs Inc, Upsher Smith Labs, Usl Pharma, Watson Labs, and Wyeth Ayerst, and is included in ninety-six NDAs. Additional information is available in the individual branded drug profile pages.
There are five drug master file entries for phendimetrazine tartrate. Eighteen suppliers are listed for this compound.
Pharmacology for phendimetrazine tartrate
|Drug Class||Sympathomimetic Amine Anorectic |
|Physiological Effect||Appetite Suppression |
Increased Sympathetic Activity
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Shire Richwood||X-TROZINE L.A.||phendimetrazine tartrate||CAPSULE, EXTENDED RELEASE;ORAL||087371-001||Aug 24, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Kv Pharm||PHENDIMETRAZINE TARTRATE||phendimetrazine tartrate||TABLET;ORAL||084141-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Mast Mm||PHENAZINE||phendimetrazine tartrate||CAPSULE;ORAL||086525-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Virtus Pharms||PHENDIMETRAZINE TARTRATE||phendimetrazine tartrate||TABLET;ORAL||085588-001||Approved Prior to Jan 1, 1982||AA||RX||No||No||Start Trial||Start Trial||Start Trial|
|Abc Holding||PHENAZINE-35||phendimetrazine tartrate||TABLET;ORAL||085512-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.